|
Folders
|
| Support for businesses |
-- |
-- |
1 Year Ago |
1 Year Ago |
|
| New COVID-19 variants |
-- |
-- |
1 Year Ago |
6 Months Ago |
|
| Independent High Risk AGP Panel |
-- |
-- |
1 Year Ago |
1 Year Ago |
|
| Daily contact testing (DCT) |
-- |
-- |
3 Months Ago |
2 Months Ago |
|
|
Documents
|
| Weekly all-cause mortality surveillance week 19 report |
178KB |
Approved |
1 Month Ago |
1 Month Ago |
|
| Vaccine effectiveness and duration of protection of covid vaccines against mild and severe COVID-19 in the UK |
1.2MB |
Approved |
9 Months Ago |
9 Months Ago |
|
| SARS-CoV-2 variant under investigation, meeting minutes |
91KB |
Approved |
1 Year Ago |
1 Year Ago |
|
| SARS-CoV-2 infections in children following the re-opening of schools and the impact of national lockdown during Autumn 2020 prospective, national observational cohort surveillance, England |
1.6MB |
Approved |
1 Year Ago |
1 Year Ago |
|
| Public health impact of mass sporting and cultural events in a rising COVID-19 prevalence in England |
465KB |
Approved |
10 Months Ago |
10 Months Ago |
|
| Power BI tool overview |
25.9MB |
Approved |
1 Year Ago |
1 Year Ago |
|
| New SARS-COV-2 variant - information and risk assessment |
2.1MB |
Approved |
1 Year Ago |
1 Year Ago |
|
| National flu and COVID-19 surveillance report 12 May 2022 week 19 |
3.5MB |
Approved |
1 Month Ago |
1 Month Ago |
|
| National flu and COVID-19 surveillance graphs 12 May 2022 week 19 |
2.9MB |
Approved |
1 Month Ago |
1 Month Ago |
|
| National flu and COVID-19 surveillance data report 12 May 2022 week 19 |
965KB |
Approved |
1 Month Ago |
1 Month Ago |
|
| MMR, MenACWY and COVID-19 University communications toolkit |
1.2MB |
Approved |
10 Months Ago |
10 Months Ago |
|
| Mitigation of risks of COVID-19 in occupational settings with a focus on ethnic minority groups |
269KB |
Approved |
1 Year Ago |
1 Year Ago |
|
| Letter of invitation for Respiratory Evidence Panel - individual and group |
144KB |
Approved |
8 Months Ago |
8 Months Ago |
|
| Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England |
135KB |
Approved |
2 Months Ago |
2 Months Ago |
|
| Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants |
973KB |
Approved |
2 Months Ago |
2 Months Ago |
|
| Effectiveness of BNT162b2 COVID-19 booster vaccine |
527KB |
Approved |
6 Months Ago |
6 Months Ago |
|
|
|
|
|
|
|